Acute leukaemia, Acute myeloid leukaemia (AML), Blood cancers, Leukaemia, Myelodysplastic syndrome (MDS)
Results
Phase 2
This trial looked at having a reduced intensity stem cell transplant straight after chemotherapy for acute myeloid leukaemia and myelodysplastic syndrome.
This trial was for people with acute myeloid leukaemia (AML) or high risk myelodysplastic syndrome (MDS) that hadn’t responded to treatment or came back after treatment.
Recruitment start: 1 August 2007
Recruitment end: 15 August 2014
Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.
Dr James Cavenagh
Barts Health NHS Trust
Experimental Cancer Medicine Centre (ECMC)
Queen Mary University of London
Last reviewed: 24 Aug 2017
CRUK internal database number: 2591
About Cancer generously supported by Dangoor Education since 2010. Learn more about Dangoor Education
Search our clinical trials database for all cancer trials and studies recruiting in the UK.
Meet and chat to other cancer people affected by cancer.
Questions about cancer? Call freephone 0808 800 40 40 from 9 to 5 - Monday to Friday. Alternatively, you can email us.
